Comparison between GMALL and BURKIMAB protocols
{"Image DocumentName": "Comparison between GMALL and BURKIMAB protocols", "Image ImageDescription": "GMALL B-ALL/NHL2002   (n=185) BURKIMAB. (HIV-negative only, n=80) Burkitt Lymphoma. B-ALL. N aaIPI>1. 47% - 76% CR. 90% 83% 86% Death under treatment. 3% 11% 5% 3 yr OS. 91% (<55yr) 79% (<55yr) 81% (<55yr) 82% (<55yr) 84% (\u226555yr) 39% (\u226555yr) 84% (\uf0b355yr) 71% (\u226555yr)      at 1 yr.  Hoelzer D, et al ASH Meeting. Abstract 518.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}